Yan Hu

1.7k total citations · 2 hit papers
37 papers, 1.4k citations indexed

About

Yan Hu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yan Hu has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Immunology. Recurrent topics in Yan Hu's work include Nanoplatforms for cancer theranostics (6 papers), MicroRNA in disease regulation (5 papers) and Immunotherapy and Immune Responses (5 papers). Yan Hu is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), MicroRNA in disease regulation (5 papers) and Immunotherapy and Immune Responses (5 papers). Yan Hu collaborates with scholars based in China, United States and Hong Kong. Yan Hu's co-authors include Kunyu Yang, Honglin Jin, Chao Wan, Jonathan F. Lovell, Yajie Sun, Jingshu Meng, Xiaomeng Dai, Jing Huang, Suke Deng and Lisen Lu and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.

In The Last Decade

Yan Hu

34 papers receiving 1.4k citations

Hit Papers

Ferroptosis‐Enhanced Immunotherapy with an Injectable Dex... 2023 2026 2024 2025 2023 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Hu China 20 685 337 294 285 217 37 1.4k
Yun Zhou China 24 857 1.3× 400 1.2× 369 1.3× 146 0.5× 186 0.9× 66 1.6k
Jingjing Yu China 22 787 1.1× 287 0.9× 421 1.4× 273 1.0× 367 1.7× 82 1.6k
Gangyang Wang China 20 770 1.1× 369 1.1× 372 1.3× 385 1.4× 490 2.3× 36 1.7k
Lulu Han China 24 702 1.0× 303 0.9× 215 0.7× 192 0.7× 96 0.4× 79 1.5k
Sheng Liu United States 22 759 1.1× 171 0.5× 271 0.9× 206 0.7× 343 1.6× 65 1.5k
Dandan Fan China 20 821 1.2× 247 0.7× 517 1.8× 159 0.6× 170 0.8× 63 1.4k
Shenqi Zhang China 22 725 1.1× 298 0.9× 291 1.0× 120 0.4× 162 0.7× 56 1.3k
Houman Kahroba Iran 22 987 1.4× 144 0.4× 476 1.6× 219 0.8× 166 0.8× 55 1.6k
Yuge Zhao China 22 524 0.8× 416 1.2× 171 0.6× 346 1.2× 153 0.7× 37 1.2k

Countries citing papers authored by Yan Hu

Since Specialization
Citations

This map shows the geographic impact of Yan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Hu more than expected).

Fields of papers citing papers by Yan Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Hu. The network helps show where Yan Hu may publish in the future.

Co-authorship network of co-authors of Yan Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Hu. A scholar is included among the top collaborators of Yan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Hu. Yan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Ling, Ping Hou, Yang Wang, et al.. (2024). B7–H1 agonists suppress the PI3K/AKT/mtor pathway by degrading p110γ and independently induce cell death. Cancer Letters. 584. 216615–216615.
3.
He, Jinming, Qiqi Zhang, Shuang Wang, et al.. (2024). Nanoradiosentizers with X ray-actuatable supramolecular aptamer building units for programmable immunostimulatory T cell engagement. Biomaterials. 315. 122924–122924.
4.
Zhou, Ziyang, Peiran Song, Miaomiao Wang, et al.. (2024). Dual-network DNA–silk fibroin hydrogels with controllable surface rigidity for regulating chondrogenic differentiation. Materials Horizons. 11(6). 1465–1483. 61 indexed citations breakdown →
5.
Sun, Yajie, Yan Hu, Yuanyuan Geng, et al.. (2024). A self‐assembled, genetically engineered, irradiated tumor cell debris vaccine. SHILAP Revista de lepidopterología. 4(5). 20220170–20220170. 9 indexed citations
6.
Hu, Yan, Peishan Hu, & Xiaozhong Peng. (2024). Paracrine function amplifies pro-tumor electrochemical signal within neuron-glioma synapses. Science China Life Sciences. 67(6). 1318–1320. 2 indexed citations
7.
Sun, Yajie, Yu Tian, Ai Huang, et al.. (2023). Engineering irradiated tumor-derived microparticles as personalized vaccines to enhance anti-tumor immunity. Cell Reports Medicine. 4(12). 101303–101303. 9 indexed citations
8.
Meng, Jingshu, Xiao Yang, Jing Huang, et al.. (2023). Ferroptosis‐Enhanced Immunotherapy with an Injectable Dextran‐Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular Carcinoma. Advanced Science. 10(20). e2300517–e2300517. 71 indexed citations breakdown →
9.
10.
Hu, Yan, Yajie Sun, Chao Wan, et al.. (2022). Microparticles: biogenesis, characteristics and intervention therapy for cancers in preclinical and clinical research. Journal of Nanobiotechnology. 20(1). 189–189. 35 indexed citations
11.
Sun, Yajie, Yan Hu, Chao Wan, et al.. (2021). Local biomaterial-assisted antitumour immunotherapy for effusions in the pleural and peritoneal cavities caused by malignancies. Biomaterials Science. 9(19). 6381–6390. 10 indexed citations
12.
Gao, Yanan, You Qin, Chao Wan, et al.. (2021). Small Extracellular Vesicles: A Novel Avenue for Cancer Management. Frontiers in Oncology. 11. 638357–638357. 54 indexed citations
13.
He, Qianyuan, Zhanjie Zhang, Haojie Liu, et al.. (2020). Relieving immunosuppression during long-term anti-angiogenesis therapy using photodynamic therapy and oxygen delivery. Nanoscale. 12(27). 14788–14800. 15 indexed citations
14.
Liu, Haojie, Yan Hu, Yajie Sun, et al.. (2019). Co-delivery of Bee Venom Melittin and a Photosensitizer with an Organic–Inorganic Hybrid Nanocarrier for Photodynamic Therapy and Immunotherapy. ACS Nano. 13(11). 12638–12652. 154 indexed citations
15.
Li, Dengke, Yan Hu, Shanshan Li, et al.. (2019). Glioma-associated human endothelial cell-derived extracellular vesicles specifically promote the tumourigenicity of glioma stem cells via CD9. Oncogene. 38(43). 6898–6912. 33 indexed citations
16.
Hu, Peishan, Shanshan Li, Fan Wu, et al.. (2019). Acidosis enhances the self-renewal and mitochondrial respiration of stem cell-like glioma cells through CYP24A1-mediated reduction of vitamin D. Cell Death and Disease. 10(1). 25–25. 50 indexed citations
17.
Zhao, Youbo, Wei Li, Menghuan Li, et al.. (2019). Targeted inhibition of MCT4 disrupts intracellular pH homeostasis and confers self-regulated apoptosis on hepatocellular carcinoma. Experimental Cell Research. 384(1). 111591–111591. 35 indexed citations
18.
Wu, Fengying, Yan Hu, Zhizhong Wei, et al.. (2017). NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma. Oncogene. 36(33). 4706–4718. 39 indexed citations
19.
Hu, Yan, Jihong Yao, Xiaohan Zhai, et al.. (2014). Sirtuin 1-Mediated Inhibition of p66shc Expression Alleviates Liver Ischemia/Reperfusion Injury. Critical Care Medicine. 42(5). e373–e381. 50 indexed citations
20.
Hu, Yan, et al.. (2014). Selection of a Novel DNA Aptamer for Assay of Intracellular Interferon-Gamma. PLoS ONE. 9(5). e98214–e98214. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026